Consolidated Portfolio Review Corp Elevance Health, Inc. Transaction History
Consolidated Portfolio Review Corp
- $723 Billion
- Q2 2025
A detailed history of Consolidated Portfolio Review Corp transactions in Elevance Health, Inc. stock. As of the latest transaction made, Consolidated Portfolio Review Corp holds 553 shares of ELV stock, worth $171,430. This represents 0.03% of its overall portfolio holdings.
Number of Shares
553
Previous 553
-0.0%
Holding current value
$171,430
Previous $241 Million
10.57%
% of portfolio
0.03%
Previous 0.04%
Shares
2 transactions
Others Institutions Holding ELV
# of Institutions
1,844Shares Held
207MCall Options Held
1.55MPut Options Held
1.14M-
Vanguard Group Inc Valley Forge, PA22.9MShares$7.09 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY20.7MShares$6.42 Billion0.26% of portfolio
-
State Street Corp Boston, MA10.6MShares$3.28 Billion0.16% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD8.09MShares$2.51 Billion0.36% of portfolio
-
Capital International Investors Los Angeles, CA6.49MShares$2.01 Billion0.45% of portfolio
About Elevance Health, Inc.
- Ticker ELV
- Exchange NYSE
- Sector Healthcare
- Industry Healthcare Plans
- Shares Outstandng 240,000,992
- Market Cap $74.4B
- Description
- Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions....